Table 2 Patients who developed hypertensive anaphylaxis and their managements
Case number | Sex/age (years) | Allergic disease | Causes of anaphylaxis | Additional symptomsa | ABP after anaphylaxisb (mmHg) | Treatment |
|---|---|---|---|---|---|---|
1. | M/20 | Bee venom allergy | Venom immunotherapy (vespula 100 mcg) | Papular urticarial lesions | 170/100 | ivAH, ivSt, nBD |
2. | M/20 | Bee venom allergy | Venom immunotherapy (Apis mellifera 80 mcg) | 220/150 | ivAH, ivSt, nBD | |
3. | M/20 | Anaphylaxis with multiple food | Prick test with multiple fresh food | Dyspnea, generalize edema | 190/120 | ivAH, ivSt, nBD |
4. | M/37 | Allergic rhinitis | Immunotherapy with HDM mix (100.000 SQ-U/ml 0.5 cc) | 170/110 | ivAH, ivSt, nBD | |
5. | F/19 | Asthma and allergic rhinitis | Immunotherapy with HDM mix (10 IR/ml 0.2 cc) | Wheezing | 150/90 | ivAH, imE, nBD |
6. | F/39 | Asthma and allergic rhinitis | Immunotherapy with HDM mix (10 IR/ml 1 cc) | Papular urticarial lesions | 150/90 | ivAH, ivSt, nBD, ACEi |
7. | F/29 | Asthma and allergic rhinitis | Immunotherapy with Phostal 350 (1 ml) | Papular urticarial lesions | 160/100 | ivAH, ivSt, nBD, ACEi |
8. | F/23 | Multiple drug, food and latex allergy, chronic urticaria, angioedema | Omalizumab treatment (300 mg/month) | Difficulty in breathing, tachycardia | 150/100 | ivAH, scE, imE, nE, ACEi |